Qi Liu
- Oncology top 2%
- Molecular Biology top 10%
- Pharmacology top 1%
- Epidemiology top 10%
- Immunology top 10%
- Topics
- Drug Transport and Resistance Mechanisms (44 papers)Liver Disease Diagnosis and Treatment (18 papers)Pharmacological Effects and Toxicity Studies (10 papers)
- Cited by
- PharmacologyOncologyHepatology
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Qi Liu
110 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 1.0k
- Molecular Biology 824
- Pharmacology 375
- Epidemiology 356
- Immunology 331
Countries citing papers authored by Qi Liu
This map shows the geographic impact of Qi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Liu more than expected).
Fields of papers citing papers by Qi Liu
This network shows the impact of papers produced by Qi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Liu. The network helps show where Qi Liu may publish in the future.
Co-authorship network of co-authors of Qi Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Qi Liu. A scholar is included among the top collaborators of Qi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Liu. Qi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 10 | |
| 6 | 53 | |
| 7 | 23 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 15 | |
| 11 | 20 | |
| 12 | 3 | |
| 13 | 25 | |
| 14 | 6 | |
| 15 | 35 | |
| 16 | 36 | |
| 17 | 23 | |
| 18 | 19 | |
| 19 | 41 | |
| 20 | 1 |
About Qi Liu
Qi Liu is a scholar working on Oncology, Pharmacology and Microbiology, having authored 111 papers that have together received 2.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (44 papers), Liver Disease Diagnosis and Treatment (18 papers) and Pharmacological Effects and Toxicity Studies (10 papers). The work is most often cited by research in Pharmacology (375 citations), Oncology (1.0k citations) and Hepatology (125 citations). Qi Liu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Changyuan Wang, Qiang Meng, Huijun Sun, Kexin Liu, Jinyong Peng, Xiaokui Huo, Zhihao Liu, Pengyuan Sun, Taiichi Kaku and Xiaochi Ma. Their work appears in journals such as Nature Communications, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.